SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001104659-12-050246
Filing Date
2012-07-23
Accepted
2012-07-23 06:09:43
Documents
3
Period of Report
2012-07-20
Filing Date Changed
2012-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-16817_18k.htm 8-K 42811
2 EX-2.1 a12-16817_1ex2d1.htm EX-2.1 362977
3 EX-99.1 a12-16817_1ex99d1.htm EX-99.1 14355
  Complete submission text file 0001104659-12-050246.txt   421516
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 12973483
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1